<p>I Basics.- 1 Anatomy and pathology of the peritoneum.- 2 Pharmacovigilance of topical chemotherapy in the peritoneum.- II Diagnostics and natural course.- 3 Imaging diagnostics of tumors of the peritoneum.- 4 Role of laparoscopy in the diagnosis of tumors of the peritoneum.- 5 Scoring systems for CRS and HIPEC.- 6 Natural course of peritoneal carcinomatosis.- III Therapy options of systemic therapy.- 7 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the upper GI tract.- 8 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the lower GI tract including appendiceal carcinoma.- IV Treatment options for surgical cytoreduction.- 9 Procedures of parietal and visceral peritonectomy in the upper abdomen.- 10 Technique of visceral and parietal peritonectomy in the lower abdomen.- 11 Procedures of parietal and visceral peritonectomy interenterically.- 12 Cytoreduction - preparation devices.- V therapy options of intraperitoneal therapy and experimental approaches.- 13 Application of IPC, HIPEC and PIPAC.- 14 Cytokine-induced senescence: an experimental therapy for peritoneal tumors.- 15 Mechanism of action and experimental and clinical data on regional hyperthermia.- 16 HIPEC in childhood.- VI Potentially curative approach.- 17 Importance of intraperitoneal chemotherapy as a prophylaxis after curative resection of a gastrointestinal carcinoma.- 18 Indication of CRS and HIPEC in Pseudomyxoma peritonei.- 19 Significance of CRS and HIPEC in mesothelioma.- 20 Indication of CRS and HIPEC in peritoneal metastatic gastric carcinoma.- 21 Indication of CRS and HIPEC in peritoneal metastases of colorectal carcinomas.- 22 Indication of CRS and HIPEC in peritoneal metastases of ovarian cancer.- 23 Indication of CRS and HIPEC in peritoneal metastases of NET and small intestinal carcinomas.- 24 Indication of CRS and HIPEC in peritoneal metastases of pancreatic carcinomas.- 25 Indications of CRS and HIPEC in Incidentally Detected Peritoneal Carcinomatosis.- VII VII Palliative treatment attempt of advanced peritoneal metastasis.- 26 Importance of systemic chemotherapy in advanced peritoneal metastasis.- 27 Importance of PIPAC in advanced peritoneal metastasis.- VIII Complications in the Palliative Chemotherapy of Peritoneal Cancer.- 28 Complications in the Palliative Chemotherapy of Peritoneal Cancer.- 29 Cytoreductive surgery for complications of peritoneal carcinomatosis.- 30 IPEC, HIPEC, Bidirectional Chemotherapy and Immunotherapy in Aggressive Peritoneal Metastasis.- IX Perioperative treatment and prophylaxis of treatment related complications.- 31 Preoperative Management: Risk Assessment, Conditioning, Nutritional Aspects, Special Preparation, Including Bowel.- 32 Safety Considerations for Intraoperative Use of Cytostatic Agents.- 33 Preventing Complications of Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy.- 34 Nutritional Concepts in Patients with Peritoneal Tumors.- 35 Perioperative management.- X Quality of life.- 36 Quality of life at CRS and HIPEC.- 37 PIPAC Therapy and Quality of Life.- XI Recurrent diesease.- 38 Follow-Up to Prevent Recurrence of Peritoneal Malignancies.- 39 Localization of Localization of Peritoneal Tumor Recurrence.- 40 Treatment Options for Peritoneal Tumor Recurrence.- XII Environmental Aspects.- 41 Importance of Psycho-Oncology for Tumors of the Peritoneum.- 42 Nursing Aspects of Peritoneal Surface Malignancy.- XIII Guidelines and centres.- 43 Guideline preparation and center development for the treatment of peritoneal tumors in Germany.- 44 Guideline preparation and center development for the treatment of peritoneal tumors in Switzerland.- Service part.- 45 Checklists for the treatment of tumors of the peritoneum. Framework SOP.- Index.</p><p></p>